Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
10,501 Dovepress* 6,557 2,757+ 562 9,314
PubMed Central* 0 1,187 153 1,187
Totals 6,557 3,944 715 10,501
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
214 0 0 0 3 211

View citations on PubMed Central and Google Scholar